BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16990769)

  • 1. T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy.
    D'Amico G; Bonamino M; Dander E; Marin V; Basso G; Balduzzi A; Biagi E; Biondi A
    Leukemia; 2006 Nov; 20(11):2015-24. PubMed ID: 16990769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia.
    Todisco E; Gaipa G; Biagi E; Bonamino M; Gramigna R; Introna M; Biondi A
    Leukemia; 2002 Oct; 16(10):2046-54. PubMed ID: 12357356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.
    Tuettenberg A; Fondel S; Steinbrink K; Enk AH; Jonuleit H
    Exp Dermatol; 2010 Jan; 19(1):44-53. PubMed ID: 19889024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
    Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
    Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
    Daudt L; Maccario R; Locatelli F; Turin I; Silla L; Montini E; Percivalle E; Giugliani R; Avanzini MA; Moretta A; Montagna D
    J Immunother; 2008 May; 31(4):385-93. PubMed ID: 18391757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.
    Liu KJ; Lu LF; Cheng HT; Hung YM; Shiou SR; Whang-Peng J; Juang SH
    Cancer Gene Ther; 2004 Feb; 11(2):135-47. PubMed ID: 14647233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [T-cell immunity against autologous leukemic cell mediated by in vitro bone marrow-derived dendritic cell from patients with acute myeloid leukemia in complete remission].
    He X; You S; Bian S
    Zhonghua Xue Ye Xue Za Zhi; 2001 Dec; 22(12):629-32. PubMed ID: 16200709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells.
    Mohty M; Isnardon D; Charbonnier A; Lafage-Pochitaloff M; Merlin M; Sainty D; Olive D; Gaugler B
    Int Immunol; 2002 Jul; 14(7):741-50. PubMed ID: 12096033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.
    Liu Y; Zhang X; Zhang W; Chen Z; Chan T; Ali K; Jia Z; Xiang J
    Cancer Gene Ther; 2002 Feb; 9(2):202-8. PubMed ID: 11857039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
    Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
    Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction of efficient T-cell immunity against autologous leukemia cells by dendritic cells pulsed with the leukemia cell total RNA].
    Ge W; You SG; Wang YF; Li CH; Liu XF; He XP; Ma S; Qiu L
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):461-4. PubMed ID: 16383235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML-loaded DC generate Th1-type cellular immune responses in vitro.
    Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ
    Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses.
    Fabricius D; Breckerbohm L; Vollmer A; Queudeville M; Eckhoff SM; Fulda S; Strauss G; Debatin KM; Jahrsdörfer B; Meyer LH
    Leukemia; 2011 Jul; 25(7):1111-21. PubMed ID: 21527935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.
    D'Amico G; Vulcano M; Bugarin C; Bianchi G; Pirovano G; Bonamino M; Marin V; Allavena P; Biagi E; Biondi A
    Blood; 2004 Aug; 104(3):744-51. PubMed ID: 15001471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
    Mohty M; Isnardon D; Blaise D; Mozziconacci MJ; Lafage-Pochitaloff M; Brière F; Gastaut JA; Olive D; Gaugler B
    Leukemia; 2002 Nov; 16(11):2267-74. PubMed ID: 12399972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
    Schmidt K; Seeger K; Scheibenbogen C; Bender R; Abdulla M; Süssmilch S; Salama A; Moldenhauer A
    J Leukoc Biol; 2009 Mar; 85(3):563-73. PubMed ID: 19129484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.